This Crypto Is Set to Explode in December

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Amelia Merrill Biography and Net Worth

SVP of Guardant Health

Amelia Merrill is the VP of People at Guardant Health Inc.

What is Amelia Merrill's net worth?: The estimated net worth of Amelia Merrill is at least $782,502.36 as of August 11th, 2022. Merrill owns 24,708 shares of Guardant Health stock worth more than $782,502 as of December 21st. This net worth evaluation does not reflect any other investments that Merrill may own. Learn More about Amelia Merrill's net worth.
How do I contact Amelia Merrill?: The corporate mailing address for Merrill and other Guardant Health executives is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Guardant Health can also be reached via phone at (855) 698-8887 and via email at [email protected]. Learn More on Amelia Merrill's contact information.
Has Amelia Merrill been buying or selling shares of Guardant Health?: Amelia Merrill has not been actively trading shares of Guardant Health within the last three months. Most recently, Amelia Merrill sold 4,500 shares of the business's stock in a transaction on Thursday, August 11th. The shares were sold at an average price of $53.38, for a transaction totalling $240,210.00. Following the completion of the sale, the senior vice president now directly owns 24,708 shares of the company's stock, valued at $1,318,913.04. Learn More on Amelia Merrill's trading history.
Who are Guardant Health's active insiders?: Guardant Health's insider roster includes Derek Bertocci (CFO), Ian Clark (Director), Helmy Eltoukhy (CEO), Meghan Joyce (Director), Kumud Kalia (Insider), Samir Kaul (Director), Stanley Meresman (Director), Amelia Merrill (SVP), and Amirali Talasaz (COO). Learn More on Guardant Health's active insiders.
Are insiders buying or selling shares of Guardant Health?: During the last year, Guardant Health insiders bought shares 1 times. They purchased a total of 2,187 shares worth more than $38,972.34. During the last year, insiders at the sold shares 6 times. They sold a total of 5,632 shares worth more than $180,115.00. The most recent insider tranaction occured on December, 18th when Director Musa Tariq sold 116 shares worth more than $4,042.60. Insiders at Guardant Health own 5.5% of the company. Learn More about insider trades at Guardant Health.
Information on this page was last updated on 12/18/2024.

Amelia Merrill Insider Trading History at Guardant Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/11/2022	Sell	4,500	$53.38	$240,210.00	24,708

Amelia Merrill Buying and Selling Activity at Guardant Health

Guardant Health Company Overview

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Today's Range

Now: $31.67

$30.49

$32.22

50 Day Range

MA: $29.13

$20.20

$38.11

2 Week Range

Now: $31.67

$15.81

$38.53

Volume

2,414,304 shs

Average Volume

2,035,487 shs

Market Capitalization

$3.91 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

This Crypto Is Set to Explode in December

From Crypto 101 Media | Ad